The 8th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference is dedicated to next gen technologies beyond conventional biomarker drug discovery.
The 8th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference covers topics such as:
- Proteomics and Genomics based Biomarkers
- Biomarker Drug Discovery and Assay Development
- Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases
- Digital Biomarkers, Predictive Biomarkers, Precision Medicine and Big Data
- Multiplex Companion Diagnostics and Regulatory Guidelines
- Commercialization of CDx
- Design of clinical trials in CDx
The 8th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference brings together attendees involved or interested in:
- Translational research
- Biomarker discovery/development
- Biomarkers in IO and Neurological disorders
- Clinical Biomarker
- Pathology
- Imaging Biomarkers
- Biomarker Imaging
- Companion Diagnostics
- Experimental Medicine
- Proteomics Biomarkers
- Biomarkers in Clinical Discovery
- Data Science
- Diagnostic Biomarkers development
- Immuno-oncology/Neuroscience Drug Discovery
- Immunology Biomarkers
- Personalized Medicine
